Literature DB >> 7989968

Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.

H Okazawa1, Y Yonekura, Y Fujibayashi, S Nishizawa, Y Magata, K Ishizu, F Tanaka, T Tsuchida, N Tamaki, J Konishi.   

Abstract

UNLABELLED: Copper-62-pyruvaldehyde bis(N4-methylthiosemicarbazone) copper II (62Cu-PTSM) has been proposed as a generator-produced positron-emitting tracer for perfusion imaging. To evaluate the characteristics of 62Cu-PTSM as a cerebral perfusion tracer, brain PET images of 62Cu-PTSM were compared with cerebral blood flow (CBF).
METHODS: Following an intravenous injection of 62Cu-PTSM, a serial dynamic PET scan was performed for 10 min with arterial sampling in 10 subjects. CBF was measured by 15O-labeled water before the 62Cu-PTSM study.
RESULTS: Dynamic PET scan with octanol-extracted arterial input function indicated the presence of significant back-diffusion of 62Cu-PTSM from the brain within 3 min after injection, followed by stable activity from 3 to 10 min. Comparison with 15O-water PET demonstrated less contrast between high- and low-flow regions in 62Cu-PTSM image and a nonlinear relationship of flow and 62Cu-PTSM uptake, which suggests the underestimation of CBF in high-flow regions due to the existence of back-diffusion.
CONCLUSION: Although 62Cu-PTSM can be used widely for evaluation of brain perfusion with PET, kinetic analysis and correction may be needed to quantify regional CBF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989968

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  A comparison of PET imaging characteristics of various copper radioisotopes.

Authors:  Heather Ann Williams; Simon Robinson; Peter Julyan; Jamal Zweit; David Hastings
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-29       Impact factor: 9.236

2.  Copper-62-pyruvaldehyde bis(N-methyl-thiosemicarbazone) PET imaging in the detection of coronary artery disease in humans.

Authors:  T R Wallhaus; J Lacy; R Stewart; J Bianco; M A Green; N Nayak; C K Stone
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

3.  Simplified quantification of regional cerebral blood flow with 99mTc-ECD SPECT and continuous arterial blood sampling.

Authors:  Y Yonekura; K Ishizu; H Okazawa; F Tanaka; N Hattori; N Sadato; T Tsuchida; S Nishizawa; N Tamaki; T Nagamine; J Konishi; H Shibasaki
Journal:  Ann Nucl Med       Date:  1996-05       Impact factor: 2.668

4.  In Vivo Quantitative Whole-Body Perfusion Imaging Using Radiolabeled Copper(II) Bis(Thiosemicarbazone) Complexes and Positron Emission Tomography (PET).

Authors:  Mark A Green; Carla J Mathias; Nathaniel J Smith; Monica Cheng; Gary D Hutchins
Journal:  Methods Mol Biol       Date:  2022

5.  Cerebral Oxidative Stress in Early Alzheimer's Disease Evaluated by 64Cu-ATSM PET/MRI: A Preliminary Study.

Authors:  Hidehiko Okazawa; Masamichi Ikawa; Tetsuya Tsujikawa; Tetsuya Mori; Akira Makino; Yasushi Kiyono; Yasunari Nakamoto; Hirotaka Kosaka; Makoto Yoneda
Journal:  Antioxidants (Basel)       Date:  2022-05-22

Review 6.  Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Authors:  J P Holland; J S Lewis; F Dehdashti
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 2.346

7.  Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine.

Authors:  D P Holschneider; J Yang; T R Sadler; N B Galifianakis; M H Bozorgzadeh; J R Bading; P S Conti; J-M I Maarek
Journal:  Brain Res       Date:  2008-07-19       Impact factor: 3.252

Review 8.  Mapping brain function in freely moving subjects.

Authors:  Daniel P Holschneider; Jean-Michel I Maarek
Journal:  Neurosci Biobehav Rev       Date:  2004-09       Impact factor: 8.989

9.  Clinical application of 62Zn/62Cu positron generator: perfusion and plasma pool images in normal subjects.

Authors:  H Okazawa; Y Fujibayashi; Y Yonekura; N Tamaki; S Nishizawa; Y Magata; K Ishizu; T Tsuchida; N Sadato; J Konishi
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.